Clearstead Advisors’s Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CRHC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-3,100
Closed -$3K 1470
2021
Q3
$3K Hold
3,100
﹤0.01% 1107
2021
Q2
$4K Hold
3,100
﹤0.01% 943
2021
Q1
$4K Buy
+3,100
New +$6.19K ﹤0.01% 904

Other funds holding CRHC.WS

Clearstead Advisors's CRHC.WS Position: Q4 2021 in Review

Clearstead Advisors sold out of Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CRHC.WS) in Q4 2021, closing a stake of 3,100 shares — an estimated $3K sold.

Clearstead Advisors first reported a position in CRHC.WS in Q1 2021 and held it in 3 quarters. The position peaked at $4K in Q2 2021. 59 funds tracked by Wall St. Rank hold CRHC.WS as of Q4 2021.

  • Clearstead Advisors reported no remaining Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2021 after selling out during the quarter.
  • Clearstead Advisors sold 3,100 Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2021, an estimated $3K.
  • Clearstead Advisors first reported a position in Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2021 and held it in 3 quarters.
  • Clearstead Advisors's Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $4K in Q2 2021.
  • 59 funds tracked by Wall St. Rank held Cohn Robbins Holdings Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2021.

Based on Clearstead Advisors's 13F filing for Q4 2021, filed 14 Feb 2022.